Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

CEL-SCI, University of Georgia to Develop LEAPS COVID-19 Immunotherapy

americanpharmaceuticalreviewMarch 24, 2020

Tag: CEL-SCI , LEAPS COVID-19 , immunotherapy

PharmaSources Customer Service